| V03AB34 |
V03AB34 fomepizole |
| V03AB35 |
V03AB35 sugammadex |
| V03AB36 |
V03AB36 phentolamine |
| V03AB37 |
V03AB37 idarucizumab |
| V03AB38 |
V03AB38 Andexanet Alfa |
| V03AC |
V03AC Iron chelating agents |
| V03AC01 |
V03AC01 Deferoxamine |
| V03AC02 |
V03AC02 deferiprone |
| V03AC03 |
V03AC03 Deferasirox |
| V03AE |
V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia |
| V03AE01 |
V03AE01 polystyrene sulfonate |
| V03AE02 |
V03AE02 Sevelamer |
| V03AE03 |
V03AE03 Lanthanum carbonate |
| V03AE04 |
V03AE04 Calcium acetate and magnesium carbonate |
| V03AE05 |
V03AE05 sucroferric oxyhydroxide |
| V03AE06 |
V03AE06 colestilan |
| V03AE07 |
V03AE07 calcium acetate |
| V03AE08 |
V03AE08 ferric citrate |
| V03AE09 |
V03AE09 patiromer calcium |
| V03AE10 |
V03AE10 Sodium Zirconium Cyclosilicate |
| V03AF |
V03AF Detoxifying agents for antineoplastic treatment |
| V03AF01 |
V03AF01 mesna |
| V03AF02 |
V03AF02 dexrazoxane |
| V03AF03 |
V03AF03 Calcium folinate |
| V03AF04 |
V03AF04 calcium levofolinate |
| V03AF05 |
V03AF05 amifostine |
| V03AF06 |
V03AF06 sodium folinate |
| V03AF07 |
V03AF07 rasburicase |
| V03AF08 |
V03AF08 palifermin |
| V03AF09 |
V03AF09 glucarpidase |